ALIPAY+
15.7.2024 09:33:27 CEST | Business Wire | Press release
In a fiercely contested UEFA EURO 2024™, Dani Olmo (Spain), Harry Kane (England), Cody Gakpo (Netherlands), Georges Mikautadze (Georgia), Ivan Schranz (Slovakia), and Jamal Musiala (Germany) emerged as joint winners of the Alipay+ Top Scorer award. Each player scored three goals during the tournament, showcasing exceptional performances throughout and contributing to a memorable event that concluded with a thrilling final at Berlin's Olympiastadion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240714542692/en/
Eric Jing, Chairman and CEO of Ant Group, presents the Alipay+ Top Scorer award to the onsite winning football player Dani Olmo of Spain at UEFA EURO 2024™ (Photo: Business Wire)
“Our warmest congratulations to the six exceptional football players for their stellar performances and for winning the Alipay+ Top Scorer award,” said Eric Jing, Chairman and CEO of Ant Group, while presenting the award at the Berlin Olympiastadion. “Just as these athletes push the boundaries of excellence with strength, ingenuity and teamwork, Alipay+ advances global commerce through digital innovation, empowering people and businesses worldwide.”
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International, is the Official Partner of UEFA EURO 2024™. The Alipay+ Top Scorer trophy, sculpted in the shape of the Chinese character “支” (pronounced zhi, meaning payment as well as support), reflects Alipay+’s dedication to supporting consumers to enjoy seamless cross-border payment and access personalised deals when using their preferred payment methods while traveling abroad.
The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that unit people across the world with passion, ambition, and solidarity. The base of the trophy resembles the ocean, consisting of 24 undulating pieces each inscribed with the names of the participating countries, while the design symbolizes the 24 teams braving the waves at the competition. The ocean also connects continents, which represents how football connects communities across the world similar to Alipay+ connecting global commerce.
Alipay+ has now enabled over 400,000 merchants in Europe, with over 120,000 in the DACH region alone. Among the 15 Alipay+ mobile partners in Germany are Alipay (Chinese mainland), AlipayHK (Hong Kong SAR, China), MPay (Macao SAR, China), Touch ’n Go eWallet and MyPB by Public Bank Berhad (Malaysia), Hipay (Mongolia), GCash (The Philippines), OCBC Digital and Changi Pay (Singapore), TrueMoney (Thailand), Tinaba (Italy), Bluecode (Germany and Austria) and Kakao Pay, Naver Pay and Toss Pay (South Korea).
“With Alipay+ and our global partnerships, global fans and visitors explore Germany, Europe and the bigger world seamlessly using their preferred payment methods. Digital commerce connects communities worldwide just like football,” said Jing. “Looking ahead, we are committed to advancing digital technologies for everyone, supporting a robust, inclusive, and sustainable global digital economy.”
About Alipay+
Alipay+ is a suite of cross-border mobile payment and digitalization technology solutions that help connect global merchants to consumers. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240714542692/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom